Concepedia

Martin Birkhofer

MB

10

Publications

958

Citations

10

H-Index

1988

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Columbia University

Bristol-Myers Squibb (Germany)

Martin Birkhofer is an author at Bristol-Myers Squibb (United States) specializing in cancer therapeutics, pharmacotherapy, and medicine.

Top concepts

Publications per year

1988–2000

10

Publications

10

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

Judith R. Abrams, Mark Lebwohl, Cynthia Guzzo et al. · Journal of Clinical Investigation · 1999 · 598 citations · Full text

Phase I and pharmacologic study of the combination paclitaxel and carboplatin as first-line chemotherapy in stage III and IV ovarian cancer.

Manon Huizing, Laurence J. van Warmerdam, Hilde Rosing et al. · Journal of Clinical Oncology · 1997 · 77 citations

Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells.

Kapil N. Bhalla, Martin Birkhofer, Z Arlin et al. · PubMed · 1988 · 74 citations

A Dose‐Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Gatifloxacin in Healthy Adult Men

Diptee A. Gajjar, Frank LaCreta, Howard D. Uderman et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2000 · 61 citations

The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.

Kapil N. Bhalla, Martin Birkhofer, Steven Grant et al. · PubMed · 1989 · 54 citations

Rows per page

1–5 of 10